News

15th Sep 2021

Spruson & Ferguson appoints David Kennedy as Managing Director for Australia

Spruson & Ferguson is pleased to announce the appointment of David Kennedy as Managing Director of the Australian business with effect from 30 August 2021. David is a highly accomplished...

Spruson & Ferguson is pleased to announce the appointment of David Kennedy as Managing Director of the Australian business...

Read More

14th Sep 2021

Aristocrat doesn’t make bank on its design: Aristocrat Technologies Australia Pty Limited [2021] ADO 1

A design application by Aristocrat Technologies Australia Pty Limited (Aristocrat) for a bank of gaming machines has been refused because the representations were inconsistent with the product name for...

A design application by Aristocrat Technologies Australia Pty Limited (Aristocrat) for a bank of gaming machines has been refused...

Read More

14th Sep 2021

Updates to the IPONZ hearing guidelines

The Intellectual Property Office of New Zealand (IPONZ) has recently implemented some changes to their procedures in trade mark proceedings. These updates are summarised below: Trial period for new hearing...

The Intellectual Property Office of New Zealand (IPONZ) has recently implemented some changes to their procedures in trade mark...

Read More

9th Sep 2021

Possible upcoming amendments to Singapore Patents Act and Patents Rules – what you need to know

The Intellectual Property Office of Singapore (“IPOS”) conducted a public consultation which ended on 12 August 2021, to seek feedback on a proposed Intellectual Property (“IP”) (Amendment) Bill 2021...

The Intellectual Property Office of Singapore (“IPOS”) conducted a public consultation which ended on 12 August 2021, to seek...

Read More

8th Sep 2021

Spruson & Ferguson and Shelston IP to combine as one firm

IPH Limited (ASX:IPH), the leading intellectual property (IP) services group in the Asia-Pacific region, today announced that two of its member firms, Shelston IP and Spruson & Ferguson Australia,...

IPH Limited (ASX:IPH), the leading intellectual property (IP) services group in the Asia-Pacific region, today announced that two of...

Read More

7th Sep 2021

Temporary changes bring certainty once again for electronic and split execution of documents for Australian corporations

The uncertainty surrounding split and electronic execution of documents has caused difficulties for Australian companies during the ongoing COVID-19 pandemic, particularly following the expiry of temporary measures under the...

The uncertainty surrounding split and electronic execution of documents has caused difficulties for Australian companies during the ongoing COVID-19...

Read More

2nd Sep 2021

Clinical Trial Roulette: patenting pharmaceuticals in Australia is now a game of chance

While the case of Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd1 (‘Mylan v Sun Pharma’) was decided a little over a year ago, some of the...

While the case of Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd1 (‘Mylan v Sun Pharma’) was...

Read More

30th Aug 2021

Australian Designs – Bill now passed

The Designs Amendment (Advisory Council on Intellectual Property Response) Bill 2020 (the Bill) was recently passed by both houses of Parliament and will soon be presented to the Governor...

The Designs Amendment (Advisory Council on Intellectual Property Response) Bill 2020 (the Bill) was recently passed by both houses...

Read More

26th Aug 2021

Dead or Alive: Statuses, Patent Expiries and Kind Codes – Part 3

I'm exploring statuses, patent expiries and kind codes in a three part series of articles.  The first article on statuses can be found here, and the second article on...

I'm exploring statuses, patent expiries and kind codes in a three part series of articles.  The first article on...

Read More

26th Aug 2021

The Australian Federal Court removes a pharmaceutical patent term extension because of the patentee’s own earlier registered goods

In Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, the Federal Court of Australia has determined that a pharmaceutical patent term extension (PTE) for a...

In Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, the Federal Court of Australia has...

Read More

24th Aug 2021

Practice note: what to do with medical use claims when employing the foreign route of prosecution in Singapore

Up until 1 January 2020, the Foreign Route was an available patent prosecution option of a Singapore application having a local or international filing date prior to 1 January...

Up until 1 January 2020, the Foreign Route was an available patent prosecution option of a Singapore application having...

Read More

18th Aug 2021

Patent term extensions in Australia: Can a “first regulatory approval” less than 5 years after the patent filing date be ignored?

Australia’s Federal Court Decision, Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, concerns a patent claiming two pharmaceutical substances having different first regulatory approval dates;...

Australia’s Federal Court Decision, Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, concerns a patent...

Read More